Insider filing · TMDX

Waleed H Hassanein bought $1.0M of TransMedics (TMDX)

Executed Nov 17 2025, disclosed Nov 18 2025, 1 day later.

Over the 21 trading sessions from the disclosed entry session (Nov 18 2025), the stock returned +9.0% (delay-adjusted); from the execution session (Nov 17 2025), +9.2%. Derived: entry at the session's open, exit at the close 20 sessions later.

WH Waleed H Hassanein President & CEO profile →

Waleed H Hassanein (President & CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in TransMedics Group, Inc. (TMDX). Across 1 priced purchase filing, the average 21-session return was +9.2% from execution and +9.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of TMDX (8,775 sh × $114.00, as filed), executed Nov 17 2025.

TMDX TransMedics Group, Inc. TMDX · Healthcare · 21 filings in 24 months ticker →

Healthcare · TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage orga…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→